NCT06855342Recruiting
Prospective Ocular Imaging for Intracranial Pressure Evaluation
Source: ClinicalTrials.gov · Last updated 3 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a prospectively recruiting, database development study collecting images and videos of the spontaneous venous pulsation at the back of people's eyes - this is a pulse one can see on examination of the back of the eye, originating from the blood vessels around the nerve that connects the eye to the brain (the optic nerve), and is present in most people who have normal pressure around the brain. However, in people with raised pressure in the brain, this pulse disappears as the pressure rises. Many things can cause the pressure around the brain to increase, including tumours, swellings and trauma. The investigators want to test if high-quality images and videos of this pulse, taken using both hand-held and larger, fixed-platform machines, can be used to train a software tool to automatically detect this pulse. The investigators want to collect these images and videos in 2 groups of patients: those with no known or suspected brain pressure problems, and those who are suspected to have raised pressure and/or are due to undergo measurement of the pressure around the brain, called lumbar punctures or intracranial pressure bolt monitoring. These tests to check the pressure around the brain are invasive - they involve inserting needles in the back or directly into the brain to measure the pressure, and carry risks. The value of these two groups of people will be to help train the software to reasonably say whether a pulse is present or absent and, hopefully, estimate what the pressure around the brain may be without the need for an invasive test.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 160 (estimated)
- First submitted
- 15 Jan 2025
- Start date
- 10 Jan 2025
- Primary completion date
- 30 Nov 2025
- Lead sponsor
- King's College Hospital NHS Trust
- Diseases
- High blood pressure
- NCT number
- NCT06855342
What you commit to
- Study type: Observational
- Planned participants: 160
- From 10 Jan 2025 to the primary completion date, 30 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or previous evidence of glaucoma, glaucoma suspect, family history of glaucoma in a 1st degree relative, or non-glaucoma related optic neuropathy in both eyes.
- Current or previous history of disorders affecting intracranial pressure including, but not limited to, idiopathic intracranial hypertension, hydrocephalus, epilepsy, intracranial bleeds, space occupying lesions or tumours, traumatic brain injury, central nervous system inflammatory or infectious disorders, congenital neuro-cranial disorders, neurosurgical or interventional procedures. Radiologically-confirmed ischaemic stroke is permissible, provided the patient did not develop a subsequent haemorrhagic stroke or require neurosurgical intervention.
- Patients due to undergo continuous ICP monitoring
- Exclusion:
- 2\. Current or previous evidence of glaucoma or glaucoma suspect in both eyes.
- 3\. Retinal vein or artery occlusions in both eyes (branch or central).
- 4\. Bed-bound patients.
- 5\. Patients who, in the opinion of the investigator, would be unwilling or unable to provide written informed consent, or undergo the testing procedures as described in the protocol.
Other illness
- Active or history of proliferative diabetic retinopathy, or diabetic papillitis in both eyes.
- Current or recent (6 months) history of medication use affecting intracranial pressure including steroids, vitamin A analogues, tetracyclines, recombinant growth hormone, lithium, nitrofurantoin, nalidixic acid, sulfenazone, cyclosporine, amiodarone.
Age
- Aged ≥18 years.
Other
- Significant media opacity restricting acquisition of retinal vein imaging and video capture in both eyes.
- Retinal vein or artery occlusions in both eyes (branch or central).
- Symptoms and/or signs that, in the opinion of the investigator, indicate possible raised intracranial pressure.
- Bed-bound patients.
- Patients who, in the opinion of the investigator, would be unwilling or unable to provide written informed consent, or undergo the testing procedures as described in the protocol.
- Patients due to undergo lumbar puncture or intracranial pressure bolt monitoring:
- Inclusion:
- Patients due to undergo lumbar puncture with measurement of Opening and Closing CSF pressures
Who the study is looking for
- Aged ≥18 years
- Presumed normal ICP undergoing routine mydriatic ophthalmology OCT scans.
Criteria the registry did not label
- Healthy controls:
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| King's Ophthalmology Research Unit Coordinator of this site? Confirm its status | London | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.